Home > Understanding Breast Cancer > Early Detection & Screening > Early Detection & Screening References

  


Early Detection & Screening References

  1. Pisano ED, Gatsonis C, Hendrick E, et al. for the Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 353(17):1773-83, 2005.
  2. Skaane P, Hofvind S, Skjennald A. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study. Radiology. 244(3):708-17, 2007.
  3. Pisano ED, Hendrick RE, Yaffe MJ, et al. for the DMIST Investigators Group. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 246(2):376-83, 2008.
  4. Morton MJ, Whaley DH, Brandt KR, Amrami KK. Screening mammograms: interpretation with computer-aided detection--prospective evaluation. Radiology. 239(2):375-83, 2006.
  5. Gilbert FJ, Astley SM, Gillan MG, et al. for the CADET II Group. Single reading with computer-aided detection for screening mammography. N Engl J Med. 359(16):1675-84, 2008.
  6. Fenton JJ, Taplin SH, Carney PA, et al. Influence of computer-aided detection on performance of screening mammography. N Engl J Med. 356(14):1399-409, 2007.
  7. American Cancer Society. Can breast cancer be found early? http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-detection?rnav=cri, 2011.
  8. Schell MJ, Yankaskas BC, Ballard-Barbash R, et al. Evidence-based target recall rates for screening mammography. Radiology. 243(3):681-9, 2007.
  9. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening. Radiology. 258(1):98-105, 2011.
  10. de Gelder R, Draisma G, Heijnsdijk EA, de Koning HJ. Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths. Br J Cancer. 104(7):1214-20, 2011.
  11. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. (1):CD001877, 2011.
  12. National Center for Health Statistics. Health, United States, 2009: with special feature on medical technology. Hyattsville, MD. 2010.
  13. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures, 2011. American Cancer Society, 2011.
  14. Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC. Recent trends in U.S. mammography use from 2000-2006: a population-based analysis. Prev Med. 47(5):477-82, 2008.
  15. American College of Radiology. BI-RADS - Mammography, Fourth Edition. Reston, VA.  http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BIRADSAtlas/BIRADSAtlasexcerptedtext/BIRADSMammographyFourthEdition.aspx, 2003.
  16. American Cancer Society. Mammogram reports. http://www.cancer.org/Treatment/UnderstandingYourDiagnosis/ExamsandTestDescriptions/MammogramsandOtherBreastImagingProcedures/mammograms-and-other-breast-imaging-procedures-mammo-report, 2010.
  17. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 363(13):1203-10, 2010.
  18. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 117(4):714-22, 2011.
  19. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L for the U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 151(10):727-37, W237-42, 2009.
  20. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow B, for the Trial Management Group. Eff ect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet. 368(9552):2053-60, 2006.
  21. Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst. 96(19):1432-40, 2004.
  22. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 151(10):716-726, 2009.
  23. Qaseem A, Snow V, Sherif K, Aronson M, Weiss KB, Owens DK for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 146(7):511-5, 2007.
  24. American Geriatrics Society. Breast cancer screening in older women. American Geriatrics Society Clinical Practice Committee. J Am Geriatr Soc. 48(7):842-4, 2000.
  25. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 60(2):99-119, 2010.
  26. Fletcher SW and Elmore JG. Clinical practice. Mammographic screening for breast cancer. N Engl J Med. 348: 1672-80, 2003.
  27. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 225(1):165-75, 2002.
  28. Oestreicher N, Lehman CD, Seger DJ, Buist DS, White E. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR Am J Roentgenol. 184(2):428-32, 2005.
  29. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 338: 1089-96, 1998.
  30. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology. 19(10):1026-34, 2010.
  31. Rossouw JE, Anderson GL, Prentice RL, et al. for the Women's Health Initiative (WHI) Investigators Writing Group. Risk and benefits of estrogen plus progestin in health postmenopausal women: Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA. 288(3):321-33, 2002.
  32. U.S. Food and Drug Administration. Menopause and hormones. http://www.fda.gov/ForConsumers/ByAudience/ForWomen/ucm118624.htm, 2009.
  33. Chlebowski RT, Hendrix SL, Langer RD, et al. for the Women's Health Initiative Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 289(24):3243-53, 2003.
  34. McTiernan A, Martin CF, Peck JD, et al. for the Women's Health Initiative Mammogram Density Study Investigators. Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst. 97(18):1366-76, 2005.
  35. Stefanick ML, Anderson GL, Margolis KL, et al. for the Women's Health Initiative Investigators. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 295(14):1647-57, 2006.
  36. Chlebowski RT, Anderson G, Pettinger M, et al. for the Women's Health Initiative Investigators. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Arch Intern Med. 168(4):370-7, 2008.
  37. McTiernan A, Chlebowski RT, Martin C, et al. for the Women's Health Initiative Investigators. Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol. 27(36):6135-43, 2009.
  38. Esserman L, Cowley H, Eberle C, et al. Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst. 94(5): 369-75, 2002.
  39. Barlow WE, Chi C, Carney PA, et al. Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst. 96(24):1840-50, 2004.
  40. Miglioretti DL, Gard CC, Carney PA, et al. When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology. 253(3):632-40, 2009.
  41. Elmore JG, Jackson SL, Abraham L, et al. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology. 253(3):641-51, 2009.
  42. Taplin S, Abraham L, Barlow WE, et al. Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst. 100(12):876-87, 2008.
  43. Bassett LW, Hendrick RE, Bassford Tl, et al. Quality determinants of mammography: Clinical practice guidelines No. 13. Agency for Health Care Policy and Research Publication No. 95-0632. Rockville, MD: Agency for Health Care policy and Research, Public Health Services, US Department of Human Services, 1994.
  44. Gøtzsche PC and Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 355: 129-34, 2000.
  45. Olsen O and Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 358: 1340-2, 2001.
  46. Chiarelli AM, Majpruz V, Brown P, Thériault M, Shumak R, Mai V. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst. 101(18):1236-43, 2009.
  47. National Cancer Institute. What you need to know about breast cancer: Symptoms. Washington, DC, National Cancer Institute, U.S. National Institutes of Health, http://www.cancer.gov/cancertopics/wyntk/breast/page5, 2009.
  48. National Cancer Institute. Fact sheet-Paget's disease of the nipple: Questions and answers. Washington, DC, National Cancer Institute, U.S. National Institutes of Health, http://www.cancer.gov/cancertopics/factsheet/sites-types/paget-breast, 2005.
  49. American Cancer Society. Breast cancer: early detection. Atlanta, GA, American Cancer Society, http://www.cancer.org/Cancer/BreastCancer/MoreInformation/BreastCancerEarlyDetection/breast-cancer-early-detection-acs-recs-signs-symptoms-br-ca, 2011.
  50. Centers for Disease Control and Prevention. Cancer: Symptoms of breast cancer. Atlanta, GA, Centers for Disease Control and Prevention. http://www.cdc.gov/cancer/breast/basic_info/symptoms.htm, 2009.
  51. Institute of Medicine and National Research Council of the National Academies. Fulfilling the potential of cancer prevention and early detection. Curry SJ, Byers T, Hewitt M, editors. National Cancer Policy Board. Washington, D.C.: The National Academies Press, 2003.
  52. Kösters JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer (review). Cochrane Database Syst Rev. Issue 3: CD003373, 2008.
  53. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 23(33):8469-76, 2005.
  54. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 148(9):671-9, 2008.
  55. Granader EJ, Dwamena B, Carlos RC. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach. Acad Radiol. 15(12):1590-5, 2008.
  56. Saslow D, Boetes C, Burke W, et al. for the American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 57(2):75-89, 2007.
  57. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Breast cancer screening and diagnosis, Version 1.2011, 2011.
  58. American Cancer Society. American Cancer Society recommendations for early breast cancer detection. http://www.cancer.org/Cancer/BreastCancer/MoreInformation/BreastCancerEarlyDetection/breast-cancer-early-detection-acs-recs, 2011.
  59. Berg WA, Blume JD, Cormack JB, et al. for the ACRIN 6666 Investigators. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 299(18):2151-63, 2008.
  60. Lehman CD, Gatsonis C, Kuhl CK, et al. for the ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 356(13):1295-303, 2007.
  61. Bernard JR Jr, Vallow LA, DePeri ER, et al. In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the mayo clinic in Florida experience. Breast J. 16(2):118-26, 2010.
  62. Pinsky RW, Helvie MA. Mammographic breast density: effect on imaging and breast cancer risk. J Natl Compr Canc Netw. 8(10):1157-64, 2010.
  63. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA. 293(10):1245-56, 2005.
  64. Kelly KM, Dean J, Comulada WS, Lee SJ. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol. 20(3):734-42, 2010.
  65. Kuhl C, Weigel S, Schrading S, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 28(9):1450-7, 2010.
  66. Helvie MA. Digital mammography imaging: breast tomosynthesis and advanced applications. Radiol Clin North Am. 48(5):917-29, 2010.
  67. Gur D, Bandos AI, Rockette HE, et al. Localized detection and classification of abnormalities on FFDM and tomosynthesis examinations rated under an FROC paradigm. AJR Am J Roentgenol. 196(3):737-41, 2011.
  68. Hruska CB, Boughey JC, Phillips SW, et al. Molecular breast imaging: a review of the Mayo Clinic experience. Am J Surg. 196(4):470-6, 2008.
  69. Schoder H, Gonen M. Screening for cancer with PET and PET/CT: Potential and limitations. J Nucl Med. 48(Suppl 1):4S-18S, 2007.
  70. Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 257(1):246-53, 2010.
  71. Freedman MT. Chapter 15. Imaging: new techniques, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.
  72. American College of Radiology. Breast imaging position statement, 2000. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BreastImgResources/dca-BreastImagingPositionStatements.aspx, 2000.
  73. U.S. Food and Drug Administration (FDA). FDA Safety Communication: Breast cancer screening - Thermography is not an alternative to mammography. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm257259.htm, 2011.
  74. American Cancer Society. Cancer Facts and Figures for African Americans 2011-2012. Atlanta, GA: American Cancer Society, 2011.
  75. Altekruse SF, Kosary CL, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2007: Fast Stats. Bethesdsa, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2007/index.html, 2010.
  76. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 272: 947-54, 1994.
  77. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 56(3):168-83, 2006.
  78. Henley SJ, King JB, German RR, Richardson LC, Plescia M for the Centers for Disease Control and Prevention (CDC). Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006. MMWR Surveill Summ. 59(9):1-25, 2010.
  79. Battaglia TA, Santana MC, Bak S, et al. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer. 116(4):913-21, 2010.
  80. Jones BA, Dailey A, Calvocoressi L, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control. 16(7):809-21, 2005.
  81. Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol. 23(31):7836-41, 2005.
  82. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer. 112(1):171-80, 2008.
  83. Jatoi I, Becher H and Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Cancer. 98: 894-9, 2003.
  84. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 20;24(9):1342-9, 2006.
  85. Miller BA, Chu KC, Hankey BF, Ries LA. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control. 19(3):227-56, 2008.
  86. Wingo PA, King J, Swan J, et al. Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. Cancer. 113(5 Suppl):1191-202, 2008.
  87. Sassi F, Luft HS, Guadagnoli E. Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis. Am J Public Health. 96(12):2165-72, 2006.
  88. Purc-Stephenson RJ, Gorey KM. Lower adherence to screening mammography guidelines among ethnic minority women in America: a meta-analytic review. Prev Med. 46(6):479-88, 2008.
  89. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer. 109(2 Suppl):348-58, 2007.
  90. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 110(10):2119-52, 2007.
  91. Mack KP, Pavao J, Tabnak F, Knutson K, Kimerling R. Adherence to recent screening mammography among Latinas: findings from the California Women's Health Survey. J Womens Health (Larchmt). 18(3):347-54, 2009.
  92. Miranda PY, Tarraf W, González HM. Breast cancer screening and ethnicity in the United States: implications for health disparities research. Breast Cancer Res Treat. 2011 Feb 6. [Epub ahead of print]
  93. Shariff-Marco S, Klassen AC, Bowie JV. Racial/ethnic differences in self-reported racism and its association with cancer-related health behaviors. Am J Public Health. 100(2):364-74, 2010.
  94. Cochran SD, Mays VM, Bowen D, et al. Cancer-related risk indicators and preventive screening behaviors among lesbians and bisexual women. Am J Public Health. 91: 591-7, 2001.
  95. Roberts SJ, Patsdaughter CA, Grindel CG, Tarmina MS. Health related behaviors and cancer screening of lesbians: results of the Boston Lesbian Health Project II. Women Health. 39(4):41-55, 2004.
  96. Rankow EJ. Breast and cervical cancer among lesbians. Womens Health Issues. 5: 123-9, 1995.
  97. Hart SL, Bowen DJ. Sexual orientation and intentions to obtain breast cancer screening. J Womens Health (Larchmt). 18(2):177-85, 2009.
  98. Altman B, Bernstein A. Disability and health in the United States, 2001–2005. Hyattsville, MD: National Center for Health Statistics. 2008.
  99. Mobley LR, Kuo TM, Clayton LJ, Evans WD. Mammography facilities are accessible, so why is utilization so low? Cancer Causes Control. 20(6):1017-28, 2009.
  100. Yankaskas BC, Dickens P, Bowling JM, et al. Barriers to adherence to screening mammography among women with disabilities. Am J Public Health. 100(5):947-53, 2010.
  101. Barr JK, Giannotti TE, Van Hoof TJ, Mongoven J, Curry M. Understanding barriers to participation in mammography by women with disabilities. Am J Health Promot. 22(6):381-5, 2008.
  102. Clark MA, Rogers ML, Wen X, et al. Repeat mammography screening among unmarried women with and without a disability. Womens Health Issues. 19(6):415-24, 2009.
  103. Centers for Disease Control and Prevention. Women with disabilities. http://www.cdc.gov/ncbddd/women/default.htm, 2011.
  104. Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 33: 190-203, 2001.
  105. Alexandraki I, Mooradian AD. Barriers related to mammography use for breast cancer screening among minority women. J Natl Med Assoc. 102(3):206-18, 2010.
  106. Ballew C, Cummings SJ, Oreskovich J. Reported barriers to cancer screening: Montana Behavioral Risk Factor Surveillance System 2007. Am J Health Promot. 24(5):311-4, 2010.   
  107. Morrow M and Harris JR. Chapter 26: Ductal carcinoma in situ and microinvasive carcinoma, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 4th edition. Lippincott Williams and Wilkins, 2010.

Updated 09/01/11

010673.gif 

Early Detection & Screening Home 

    

Related Links

Visited by Others

Komen Videos